On a mobile device? Click here.
Abbott Laboratories announced on Wednesday that it will cut about 700 positions in the United States and Puerto Rico, largely as part of a restructuring of its stent-manufacturing business. |
Copyright (c) 2012, Chicago Tribune |
No comments:
Post a Comment